Published in Cancer Epidemiol Biomarkers Prev on January 01, 1999
Trends in black-white differentials in dietary intakes of U.S. adults, 1971-2002. Am J Prev Med (2007) 2.52
A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med (2007) 2.49
Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate (2010) 2.40
Prostate cancer epidemiology in the United States. World J Urol (2012) 2.16
Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA Oncol (2015) 2.06
Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer (2000) 1.73
Impact of meat consumption, preparation, and mutagens on aggressive prostate cancer. PLoS One (2011) 1.52
Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use. Cancer (2009) 1.28
Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California. Cancer Causes Control (2009) 1.28
Physiological and ecological significance of biological ice nucleators. Philos Trans R Soc Lond B Biol Sci (2002) 1.22
Dairy products, calcium and prostate cancer risk. Br J Cancer (2006) 1.18
Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis (2011) 1.10
Are the health attributes of lycopene related to its antioxidant function? Arch Biochem Biophys (2008) 1.08
Grilled meat consumption and PhIP-DNA adducts in prostate carcinogenesis. Cancer Epidemiol Biomarkers Prev (2007) 1.06
Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death. Cancer Epidemiol Biomarkers Prev (2012) 1.05
Risk factors for prostate cancer. Nat Clin Pract Urol (2009) 1.03
The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo. PLoS One (2013) 1.03
Racial differences in PSA screening interval and stage at diagnosis. Cancer Causes Control (2010) 1.02
Meat consumption, cooking practices, meat mutagens, and risk of prostate cancer. Nutr Cancer (2011) 1.01
A review of African American-white differences in risk factors for cancer: prostate cancer. Cancer Causes Control (2010) 0.99
Diabetes mellitus and prostate cancer risk among older men: population-based case-control study. Br J Cancer (2004) 0.99
Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J Cancer Res Clin Oncol (2004) 0.96
Lipid rafts and caveolae in signaling by growth factor receptors. Open Biochem J (2007) 0.96
Impact of consumption of vegetable, fruit, grain, and high glycemic index foods on aggressive prostate cancer risk. Nutr Cancer (2011) 0.92
Serum ferritin levels and transferrin saturation in men with prostate cancer. J Natl Med Assoc (2004) 0.91
Potential for prostate cancer prevention through physical activity. World J Urol (2011) 0.89
Dietary calcium and risk for prostate cancer: a case-control study among US veterans. Prev Chronic Dis (2012) 0.86
Patterns of meat intake and risk of prostate cancer among African-Americans in a large prospective study. Cancer Causes Control (2011) 0.84
Serum retinol and risk of prostate cancer. Am J Epidemiol (2011) 0.83
Diet and prostate cancer prevention. World J Urol (2012) 0.83
Dietary factors and risk for advanced prostate cancer. Eur J Cancer Prev (2014) 0.83
Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression. Am J Clin Nutr (2016) 0.82
Update on prostate cancer in black men within the UK. Ecancermedicalscience (2014) 0.81
Pleiotropy between genetic markers of obesity and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2013) 0.78
Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort. Oncotarget (2016) 0.77
The potential for prostate cancer chemoprevention. Rev Urol (2002) 0.77
Complementary medicine for prostate cancer: effects of soy and fat consumption. Rev Urol (2001) 0.76
Dietary Total Antioxidant Capacity is Inversely Associated with Prostate Cancer Aggressiveness in a Population-Based Study. Nutr Cancer (2016) 0.75
Change in quality of life and immune markers after a stay at a raw vegan institute: a pilot study. Complement Ther Med (2008) 0.75
Obesity and Prostate Cancer: A Focused Update on Active Surveillance, Race, and Molecular Subtyping. Eur Urol (2016) 0.75
Incidence of prostate and urological cancers in England by ethnic group, 2001-2007: a descriptive study. BMC Cancer (2015) 0.75
Increased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis (2017) 0.75
National economic and development indicators and international variation in prostate cancer incidence and mortality: an ecological analysis. World J Urol (2016) 0.75
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst (1993) 9.48
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med (1969) 6.54
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res (1995) 5.72
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials (2000) 5.37
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09
Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst (1993) 5.07
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA (1994) 4.35
Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Selection of controls in case-control studies. I. Principles. Am J Epidemiol (1992) 3.94
Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol (1992) 3.80
Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst (1996) 3.76
Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72
Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica (1997) 3.67
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA (1986) 3.63
Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group. J Natl Cancer Inst (1997) 3.61
Population declines in North American birds that migrate to the neotropics. Proc Natl Acad Sci U S A (1989) 3.58
Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst (1997) 3.57
Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36
Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30
Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol (1997) 3.10
Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet (1977) 3.05
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst (1995) 3.03
Cancer incidence and mortality trends in the United States: 1935-74. J Natl Cancer Inst (1978) 3.01
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00
Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98
Pesticides and other agricultural risk factors for non-Hodgkin's lymphoma among men in Iowa and Minnesota. Cancer Res (1992) 2.92
Selection of controls in case-control studies. III. Design options. Am J Epidemiol (1992) 2.88
An occupation and exposure linkage system for the study of occupational carcinogenesis. J Occup Med (1980) 2.84
Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst (1995) 2.83
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Clinical prediction of acute aortic dissection. Arch Intern Med (2000) 2.81
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76
Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
Random digit dialing in selecting a population-based control group. Am J Epidemiol (1984) 2.64
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
The emerging epidemic of melanoma and squamous cell skin cancer. JAMA (1989) 2.61
A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
Growth and decay of pulmonary function in healthy blacks and whites. Respir Physiol (1978) 2.55
Lung cancer in nonsmoking women: a multicenter case-control study. Cancer Epidemiol Biomarkers Prev (1993) 2.53
Aminophylline therapy for acute bronchospastic disease in the emergency room. Ann Intern Med (1991) 2.51
Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst (1969) 2.50
International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50
Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol (1991) 2.49
Mathematical modeling strategies for the analysis of epidemiologic research. Annu Rev Public Health (1985) 2.48
Mammographic densities and risk of breast cancer. Cancer (1991) 2.47
Attributable risk: advantages of a broad definition of exposure. Am J Epidemiol (1994) 2.45
Geographic patterns of lung cancer: industrial correlations. Am J Epidemiol (1976) 2.45
Rheumatoid arthritis and cancer risk. Eur J Cancer (1996) 2.44
Risk of breast cancer to relatives of young breast cancer patients. J Natl Cancer Inst (1985) 2.43
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43
Artificial sweeteners and human bladder cancer. Preliminary results. Lancet (1980) 2.42
Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev (2002) 2.36